Test shot medicine versus insulin pump for new type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study compares a continuous “under the skin” diabetes medicine (called beinaglutide) with an insulin pump (CSII) in people who were recently diagnosed with type 2 diabetes. It aims to see which approach works better and is safer for controlling blood sugar.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 to 70 years old, and you can join by signing consent.
- You were recently diagnosed with type 2 diabetes (within 1 year).
- Your A1c (an average blood sugar test) is between 7.5% and 10.0%.
- Your weight is in a BMI range of 24 to 42.
- You have not used diabetes medicines for long—either none, or pills for less than 3 months then stopped for at least 1 month.
- You can use effective birth control during the study and for 1 month after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two injectable medications, RAY1225 and semaglutide, added to your usual diabetes pills, to see how well they control blood sugar and affect weight. It aims to help improve glucose control in people with type 2 diabetes.
This study tests whether a new injection that combines insulin with liraglutide works better than standard premixed insulin for people with type 2 diabetes. It aims to improve blood sugar control and simplify treatment.
This study tests a new once-weekly injectable medication (HDM1005) for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise or metformin alone. It aims to help lower blood sugar and may also support weight loss.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This trial compares two treatment approaches—liraglutide injections versus a specific insulin (glargine) injection—plus meal-time insulin dosing (“bolus”) in adults with overweight/obesity and type 2 diabetes that isn’t well controlled. The goal is to see which option works better and is safer for improving blood sugar.
This study compares an insulin pump to insulin shots to see which better improves blood sugar control and reduces swings in people with type 1 diabetes. You may be included if your diabetes is not well controlled despite education and you’ve had low blood sugar episodes.
Hear when a new Type 2 Diabetic Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.